Long non-coding RNAs and hepatocellular carcinoma
- PMID: 25469263
- PMCID: PMC4251171
- DOI: 10.3892/mco.2014.429
Long non-coding RNAs and hepatocellular carcinoma
Abstract
Recent advances in next-generation sequencing technology in transcriptome analysis have helped identify numerous non-coding RNAs. The long non-coding RNA (lncRNA) is commonly defined as an RNA molecule with a length of 200 bp-100 kbp that lacks protein-coding potential. LncRNAs play a critical role in the regulation of gene expression, including chromatin modification, transcription and post-transcriptional processing. It has been confirmed that dysregulation of lncRNAs is associated with a number of human diseases, particularly tumors. In this study, we focused on the most extensively investigated lncRNAs in hepatocellular carcinoma (HCC). The biological functions and molecular mechanisms of the majority of lncRNAs have yet to be investigated. The improved knowledge on lncRNAs in HCC may help identify lncRNAs that may be used as novel prognostic markers and therapeutic targets.
Keywords: H19; HOX antisense intergenic RNA; downregulated expression by HBx; hepatocellular carcinoma; high expression in HCC; highly upregulated in liver cancer; long non-coding RNA; maternally expressed gene 3; metastasis associated lung adenocarcinoma transcript 1; microvascular invasion in HCC.
References
-
- Zheng J, Lin Z, Dong P, et al. Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med. 2013;32:17–24. - PubMed
-
- Zheng J, Dong P, Gao S, Wang N, Yu F. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma. Hepatogastroenterology. 2013;60:549–552. - PubMed
-
- Zheng J, Wu C, Lin Z, et al. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation - a novel mechanism suppressing liver fibrosis. FEBS J. 2014;281:88–103. - PubMed
-
- Huang B, Zhang R. Regulatory non-coding RNAs: revolutionizing the RNA world. Mol Biol Rep. 2014 Feb 19; (Epub ahead of print) - PubMed
-
- Gehrau RC, Mas VR, Villamil FG, et al. MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. Am J Transplant. 2013;13:729–737. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources